IP Library Granted Patent US 10,240,196
Granted Patent B2
US 10,240,196 · App. 15/167,823 · Granted Mar 26, 2019

Transposase-random priming DNA sample preparation

Inventors: Bahram Arezi (Carlsbad, CA); Michael Borns (Escondido, CA); Holly Hogrefe (San Diego, CA); Connie Hansen (San Diego, CA)
Assignee: AGILENT TECHNOLOGIES, INC.
C12Q1/6874C12Q1/6806C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,240,196
App. No.
15/167,823
Filed
May 27, 2016
Granted
Mar 26, 2019
Kind
B2
Art Unit
1637
USPC
435/6.12
Abstract

Provided herein, among other things, are a variety of methods for transposase-mediated tagging and amplification of short DNA fragments, e.g., between about 150 bp and 1.5 Kb in length. In some aspects, the method includes tagging the DNA fragments with a first primer sequence using barcoded transposases followed by a primer extension reaction to introduce a second primer sequence, e.g., using random or gene-specific primers. Kits for performing this method are also provided.

Claims (35)

1. A method comprising:

(a) contacting a sample comprising double stranded DNA fragments having an average length of from 150 bp to 1.5 Kb with a plurality of transposase duplexes each loaded with an adapter to produce adapter-tagged fragments, wherein the adapter comprises a duplex region comprising a transposase recognition sequence and a 5′ overhang region comprising a first primer sequence;

(b) performing a primer extension reaction on the adapter tagged fragments using a random primer to produce random primer extension products, wherein the random primer comprises a random 3′ sequence and a 5′ sequence comprising a second primer sequence;

(c) amplifying the random primer extension products of (b) by polymerase chain reaction (PCR) using a forward primer comprising the first primer sequence at its 3′ end and a reverse primer comprising the second primer sequence at its 3′ end to produce PCR amplification products.

2. The method of claim 1 , wherein prior to step (b) the method further comprises:

(i) performing an extension or extension/ligation reaction on the adapter tagged fragments to fill in the 5′ overhang region and fill in gaps of the adapter tagged fragments; and

(ii) performing at least one linear amplification reaction with a linear amplification primer comprising the first primer sequence at its 3′ end.

3. The method of claim 2 , wherein step (ii) comprises performing between 2 and 30 linear amplification reactions.

4. The method of claim 1 , wherein:

the first primer sequence is a first sequencing primer sequence, the forward primer comprises a 5′ tail comprising a first sequencing primer sequence, or the adapter further comprises a first sequencing primer sequence downstream of the first primer sequence; and

the second primer sequence is a second sequencing primer sequence, the reverse primer comprises a 5′ tail comprising a second sequencing primer sequence, or the random primer further comprises a second sequencing primer sequence downstream of the second primer sequence.

5. The method of claim 4 , wherein the first and second sequencing primer sequences are for next generation sequencing applications.

6. The method of claim 4 , wherein:

the adapter further comprises a barcode downstream of the first sequencing primer sequence; and/or

the random primer further comprises a barcode downstream of the second sequencing primer sequence.

7. The method of claim 6 , wherein the barcode in the adapter and/or random primer is a sample-specific barcode.

8. The method of claim 6 , wherein the barcode in the adapter and/or random primer comprises a degenerate base region (DBR).

9. The method of claim 4 , further comprising sequencing the PCR amplification products to obtain sequence reads for at least a subset of DNA fragments in the sample and assembling the sequence reads into contigs.

10. The method of claim 1 , wherein the sample of DNA fragments is isolated from a clinical sample.

11. The method of claim 10 , wherein the clinical sample is cell-free DNA extracted from a bodily fluid.

12. The method of claim 11 , wherein the bodily fluid is blood.

13. The method of claim 10 , wherein the clinical sample is a formalin-fixed and paraffin embedded (FFPE) sample.

14. A method comprising:

(a) contacting a sample comprising double stranded DNA fragments having an average length of less than 1 kb with a plurality of transposase duplexes each loaded with an adapter to produce adapter-tagged fragments, wherein the adapter comprises a duplex region comprising a transposase recognition sequence and a 5′ overhang region comprising a first primer sequence;

(b) adding an oligo-dN tail to the top strand of the adapter-tagged fragments using an enzyme with terminal transferase activity to produce tailed adapter-tagged fragments;

(c) performing a primer extension reaction on the tailed adapter-tagged fragments using a tail primer to produce tail primer extension products, wherein the tail primer comprises a 3′ sequence that hybridizes to the oligo-dN tail and a 5′ sequence comprising a second primer sequence;

(d) amplifying the tail primer extension products of (c) by polymerase chain reaction (PCR) using a forward primer comprising the first primer sequence at its 3′ end and a reverse primer comprising the second primer sequence at its 3′ end to produce PCR amplification products.

15. The method of claim 14 , further comprising sequencing the PCR amplification products to obtain sequence reads for at least a subset of DNA fragments in the sample and assembling the sequence reads into contigs.

16. The method of claim 14 , wherein the sample of DNA fragments is isolated from a clinical sample, wherein the clinical sample is a formalin-fixed and paraffin embedded (FFPE) sample.

17. A kit comprising:

a plurality of transposase duplexes each loaded with an adapter, wherein the adapter comprises a duplex region comprising a transposase recognition sequence and a 5′ overhang region comprising a first primer sequence;

a random primer comprising a random 3′ sequence and a 5′ sequence comprising a second primer sequence, or a tail primer comprising a 3′ sequence that hybridizes to an oligo-dN tail and a 5′ sequence comprising the second primer sequence;

a forward primer comprising the first primer sequence at its 3′ end;

a reverse primer comprising the second primer sequence at its 3′ end; and

one or more additional reagents for performing the method of claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2016
From: AREZI, BAHRAM; BORNS, MICHAEL; HOGREFE, HOLLY; HANSEN, CONNIE
To: AGILENT TECHNOLOGIES, INC.
Reel/Frame 038989/0611 →
Continuity (1)
Related Publication 20170342483A1 · Nov 30, 2017
Cited By (3)
US 12,571,038 US 12,606,859 US 12,630,874